Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04008108
Other study ID # APHP190234
Secondary ID 2019-A00680-57
Status Recruiting
Phase N/A
First received
Last updated
Start date July 29, 2019
Est. completion date January 29, 2024

Study information

Verified date February 2023
Source Assistance Publique - Hôpitaux de Paris
Contact Pierre MOZER, PU-PH
Phone 01 42 17 72 97
Email pierre.mozer@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The management of urinary incontinence seems to improve daily activities and the practice of physical activity, according to the literature. Unfortunately, all of these studies are based on self-questionnaires with the disadvantages of self-evaluation, more subjective. For several years activity sensors have been used in the medical field (rheumatology, cardiology, diabetology, etc.). They allowed the evaluation of physical activity in real life situations, whether to evaluate the degree of severity of a pathology or the impact of a new treatment on the resumption of activities. Activity sensors are devices that transform body motion into digital measurements. They provide detailed information on the frequency, duration, intensity and type of movement to determine, for example, the number of steps taken, the distance traveled, calories burned and the quality of sleep. It is hypothesized that urinary incontinence treatment can increase physical activity and so improve the quality of life of patients, that can be measure by activity sensors.


Description:

The management of urinary incontinence seems to improve daily activities and the practice of physical activity, according to the literature. Unfortunately, all of these studies are based on self-questionnaires with the disadvantages of self-evaluation, more subjective. The artificial urinary sphincter (AUS) implantation is an effective treatment on stress urinary incontinence in men and women. Currently the PadTest/24 hours is the reference for his evaluation. For several years activity sensors have been used in the medical field (rheumatology, cardiology, diabetology, etc.). They allowed the evaluation of physical activity in real life situations, whether to evaluate the degree of severity of a pathology or the impact of a new treatment on the resumption of activities. Activity sensors are devices that transform body motion into digital measurements. They provide detailed information on the frequency, duration, intensity and type of movement to determine, for example, the number of steps taken, the distance traveled, calories burned and the quality of sleep. It is hypothesized that urinary incontinence treatment can increase physical activity and so improve the quality of life of patients, that can be measure by activity sensors. The research is a monocentric, prospective study. The Primary objective of this study is to evaluate the variation of physical activity measured by the number of steps per day, before AUS implantation and 3 months after the activation of the sphincter. For that, the primary outcome measure is the number of steps per day measured 24h/24 for 7 consecutive days by activity sensor, before AUS implantation and 3 months after activation of the sphincter. All adult patients (men and women) with a surgical indication for urinary incontinence treatment by AUS in the urology department of Pitié-Salpêtrière hospital will be screened for eligibility. Four visits will be programed as standard of care : - During the first visit, patients will be informed of the study and their agreement will be recorded. Patients' eligibility will be checked. - AUS implantation - AUS activation - AUS follow-up, around fourteen weeks after activation The activity sensor, the Pad/Test/24 hours and questionnaires such as eQOL will be performed at home before AUS implantation, 1 month after the AUS activation and 3 months after the AUS activation.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date January 29, 2024
Est. primary completion date July 29, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Surgical indication of urinary incontinence treatment with artificial urinary sphincter implantation - Patient informed and not opposed to the research - Reading and speaking comprehension of the French language Exclusion Criteria: - Patient under guardianship or curators - Contraindication to the placement of an artificial urinary sphincter - Patients requiring walking assistance (canes, walker, wheelchair) - Revisions of artificial urinary sphincter already implanted - Cognitive impairment deemed incompatible with research

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Activity sensor
Activity sensor worn on the wrist during 7 days, 24h/24 to evaluate physical activity of patient (measured by the number of step per day) before and after Artificial Urinary Sphincter Implantation.

Locations

Country Name City State
France Service d'Urologie, Hôpital Pitié-Salpêtrière Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of steps per day, during 7 days at 3 months of the AUS activation Number of steps per day measured 24h/24 for 7 consecutive days by the activity sensor, at 3 months after activation of the AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Through the study completion, an average of 8 months
Secondary Number of steps per day, during 7 days, at 1 month of the AUS activation Number of steps per day measured 24h/24 for 7 consecutive days by the activity sensor, at 1 month after activation of the AUS.
1 month after activation of the AUS is corresponding to 24 weeks from the inclusion (6 months).
Through the study completion, an average of 6 months
Secondary Other activity sensor data (heart rate) Heart rate measured by the activity sensor preoperatively and at 1 month and 3 months after activation of the AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Through the study completion, an average of 8 months
Secondary Other activity sensor data (sedentary and activity percentage in the day) Sedentary and activity percentage a day measured by the activity sensor preoperatively and at 1 month and 3 months after activation of the AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Through the study completion, an average of 8 months
Secondary Incontinence Quality of Life (I-QOL) I-QOL is a self-report Quality of Life measure specific to urinary problems. The I-QOL is commonly used and consists of 22 items, all of which use a five-point ordinal response scale in which 1 = extremely, 2 = quite a bit, 3 = moderately, 4 = a little, and 5 = not at all.
I-QOL scores are transformed to a 0-100 scale for easy interpretability. Higher scores indicate better quality of life.
Scale score = ((The sum of the items - lowest possible score) / Possible raw score range ) x 100.
Questionnaire I-QoL fulfilled before implantation and 3 months after activation of AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Through the study completion, an average of 8 months
Secondary International Physical Activity Questionnaire (IPAQ) IPAQ is a 8 items questionnaire that assess 3 types of activity (walking, moderate-intensity activities and vigorous-intensity activities) in the following domains: leisure time, domestic/gardening, work-related, transport-related. It provide separate scores on each type of activity. Computation of the total score requires summation of the duration (in minutes) and frequency (days) of each type of activity. A Metabolic Equivalent Task (MET) is a multiple of the estimated resting energy expenditure.
Walking MET-minutes/week=3.3*walking minutes*walking days Moderate MET-minutes/week=4.0*moderate-intensity activity minutes*moderate days Vigorous MET-minutes/week=8.0*vigorous-intensity activity minutes*vigorous-intensity days Total =sum of Walking+Moderate+Vigorous METminutes/week scores.
Questionnaire IPAQ fulfilled before implantation and 3 months after activation of AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Through the study completion, an average of 8 months
Secondary PAD-test / 24h PAD-test / 24h performed at home preoperatively and 3 months after activation of AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Through the study completion, an average of 8 months
See also
  Status Clinical Trial Phase
Recruiting NCT05534412 - A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence N/A
Recruiting NCT05515198 - Improving Care for Women With Urinary Incontinence (EMPOWER) N/A
Completed NCT04071301 - Collection of Real-life Measurement Data for TENA SmartCare Change Indicator in Subjects With Urinary Incontinence N/A
Completed NCT03623880 - Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders N/A
Recruiting NCT05880862 - Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls Early Phase 1
Recruiting NCT04159467 - Effect of Pelvic Floor Muscle Training on Urinary Incontinence Reports in Obese Women Undergoing a Low Calorie Diet N/A
Completed NCT05485922 - Performance of a Single-use Intermittent Micro-hole Zone Catheter N/A
Completed NCT06268782 - The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women N/A
Not yet recruiting NCT03027986 - Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy N/A
Recruiting NCT02490917 - ACT™ Balloons Versus Artificial Urinary Sphincter (AMS800™) for the Treatment of Female Stress Urinary Incontinence N/A
Enrolling by invitation NCT02529371 - Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients N/A
Enrolling by invitation NCT02530372 - Feasibility of the UriCap-F for Urine Collection in Hospitalized Women N/A
Completed NCT02600676 - Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis N/A
Completed NCT02338726 - Pelvic Floor Symptoms and Quality of Life in Elderly Women - a Population-based Pilot Study N/A
Completed NCT02549729 - Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy N/A
Completed NCT02239796 - Feasibility Controlled Trial of Tibial Nerve Stimulation for Stroke Related Urinary Incontinence N/A
Completed NCT02368262 - Prevalence of Incontinence and Risk Factors in Children With Cerebral Palsy N/A
Completed NCT01942681 - Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride N/A
Recruiting NCT01804153 - Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO) Phase 1/Phase 2
Completed NCT01520948 - Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease Phase 3